GLP-1s and other weight
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
reconstituted material should be refrigerated and used within typical research timelines
state laws on compounded medication shipping may limit availability in some locations No lifestyle coaching, no bundled lab work, no long-term commitment required One of the few telehealth companies that discloses the compounding pharmacy used on the product page FDA warning letter received September 9, 2025 (see below) No named medical director publicly disclosed Approach: LumiMeds was founded in 2023 to make GLP-1 weight loss medication more accessible through affordable compounded options, promoting a friendly, no-surprises model that keeps pricing simple and care personalized, with a focus on convenience and value without the upsells or ongoing fees found with larger competitors
Here in Hanceville, our patients enjoy sustained weight loss and improved metabolism with tirzepatide versus Ozempic